Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 656,106 | 575,099 | 469,432 | 455,874 | 429,972 |
| Income taxes - deferred | -41,573 | 93,576 | 11,524 | 53,279 | N/A |
| Accounts receivable | -302,990 | -227,145 | -37,837 | -52,327 | -204,046 |
| Accounts payable and accrued liabilities | 526,993 | 193,457 | 153,179 | 178,184 | N/A |
| Other Working Capital | -15,733 | -202,151 | 98,614 | 130,669 | -306,683 |
| Other Operating Activity | 969,974 | 1,097,897 | 778,654 | 776,138 | 1,196,791 |
| Operating Cash Flow | $1,792,777 | $1,530,734 | $1,473,565 | $1,541,817 | $1,116,033 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -855,696 | -756,533 | -527,269 | -503,319 | -440,192 |
| Net Acquisitions | -59,590 | -1,456,236 | -345,759 | -1,221,621 | -1,369,763 |
| Investing Cash Flow | $-915,287 | $-2,212,769 | $-873,028 | $-1,724,941 | $-1,809,955 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10,804 | -24,137 | -11,380 | -9,793 | -30,073 |
| Debt Issued | 5,520 | 2,393,570 | 319,565 | 3,592,217 | 2,087,895 |
| Debt Repayment | -297,132 | -1,355,231 | -447,180 | -2,713,796 | -738,555 |
| Common Stock Issued | N/A | 0 | 25,190 | N/A | N/A |
| Common Stock Repurchased | N/A | 0 | -365,721 | N/A | N/A |
| Dividend Paid | -240,779 | -261,431 | -214,454 | -205,468 | -216,535 |
| Other Financing Activity | -378,361 | -90,762 | 108,815 | -309,029 | -490,771 |
| Financing Cash Flow | $-921,556 | $662,009 | $-585,166 | $354,131 | $611,962 |
| Exchange Rate Effect | -33,091 | -20,205 | -19,182 | 3,471 | 31,364 |
| Beginning Cash Position | 579,762 | 561,488 | 498,265 | 345,777 | 403,420 |
| End Cash Position | 502,606 | 521,257 | 494,453 | 520,255 | 352,824 |
| Net Cash Flow | $-44,066 | $-20,026 | $15,371 | $171,007 | $-81,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,792,777 | 1,530,734 | 1,473,565 | 1,541,817 | 1,116,033 |
| Capital Expenditure | -871,619 | -766,133 | -541,642 | -510,629 | -461,275 |
| Free Cash Flow | 921,158 | 764,602 | 931,923 | 1,031,188 | 654,758 |